Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public











Title  Creator  Group name  Publishing year 
Why Is Wnt/?-Catenin Not Yet Targeted in Routine Cancer Care? de Pellegars-Malhortie et al. EquipeMY 2024-07-16
Vitamin C enhances co-localization of novel TET1 nuclear bodies with both Cajal and PML bodies in colorectal cancer cells El Osmani et al. EquipeMY 2024-12
Comparison of the structures and topologies of plasma extracted circulating nuclear and mitochondrial cell-free DNA Pisareva et al. EquipeMY 2023
A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancer Grosgeorges et al. EquipeMY 2023-02-15
Assessment of Dendrigrafts of Poly- l -lysine Cytotoxicity and Cell Penetration in Cancer Cells Granier et al. EquipeMY 2022-02-11
Hypoxia differently modulates the release of mitochondrial and nuclear DNA Otandault et al. EquipeMY Jan 13, 2020
Modulating PKC? Activity to Target Wnt/?-Catenin Signaling in Colon Cancer Dupasquier et al. EquipeMY May 18, 2019
A Cell Model Suitable for a High-Throughput Screening of Inhibitors of the Wnt/?-Catenin Pathway Grimaldi et al. PlateformePCC 2018
The dose-dependent effect of SOX9 and its incidence in colorectal cancer Prévostel and Blache EquipeMY 11 2017
SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling Prévostel et al. EquipeMY Dec 13, 2016


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés